Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
$0.00
$0.97
$4.56
$16.16M1.38197,338 shs57,700 shs
TC Energy Co. stock logo
TRP
TC Energy
$49.89
-0.4%
$48.79
$37.07
$51.34
$51.86B0.782.51 million shs1.24 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00%0.00%0.00%0.00%0.00%
TC Energy Co. stock logo
TRP
TC Energy
-0.31%+0.04%-0.67%+12.45%+30.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
TC Energy Co. stock logo
TRP
TC Energy
3.8663 of 5 stars
2.44.01.70.82.81.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00
N/AN/AN/A
TC Energy Co. stock logo
TRP
TC Energy
2.83
Moderate Buy$62.0024.28% Upside

Current Analyst Ratings Breakdown

Latest LOGP, SYN, TRP, and RBD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2025
TC Energy Co. stock logo
TRP
TC Energy
Cibc World Mkts
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/2/2025
TC Energy Co. stock logo
TRP
TC Energy
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Sector Outperform
4/4/2025
TC Energy Co. stock logo
TRP
TC Energy
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Neutral
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/A$4.95 per shareN/A
TC Energy Co. stock logo
TRP
TC Energy
$13.89B3.74$5.64 per share8.85$25.19 per share1.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
-$14.27M-$1.21N/AN/AN/AN/A-26.14%-22.74%N/A
TC Energy Co. stock logo
TRP
TC Energy
$3.43B$3.0315.4017.754.3429.40%12.12%3.54%8/7/2025 (Estimated)

Latest LOGP, SYN, TRP, and RBD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
TC Energy Co. stock logo
TRP
TC Energy
$0.70$0.66-$0.04$0.65$2.57 billion$1.78 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/AN/A
TC Energy Co. stock logo
TRP
TC Energy
$2.364.73%+2.46%77.89%1 Years

Latest LOGP, SYN, TRP, and RBD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
TC Energy Co. stock logo
TRP
TC Energy
quarterly$0.61424.9%6/30/20256/30/20257/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/A
4.14
4.14
TC Energy Co. stock logo
TRP
TC Energy
1.56
0.55
1.23

Institutional Ownership

CompanyInstitutional Ownership
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
74.38%
TC Energy Co. stock logo
TRP
TC Energy
83.13%

Insider Ownership

CompanyInsider Ownership
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
2.15%
TC Energy Co. stock logo
TRP
TC Energy
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
1615.84 million15.50 millionNot Optionable
TC Energy Co. stock logo
TRP
TC Energy
7,4801.04 billionN/AOptionable

Recent News About These Companies

What is Zacks Research's Estimate for TC Energy Q2 Earnings?
Zacks Research Brokers Lift Earnings Estimates for TC Energy
US Capital Advisors Forecasts TC Energy FY2027 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Synthetic Biologics stock logo

Synthetic Biologics NYSEAMERICAN:SYN

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11 to treat cancer. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Synthetic Biologics, Inc. is headquartered in Rockville, Maryland.

TC Energy stock logo

TC Energy NYSE:TRP

$49.89 -0.20 (-0.41%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$49.90 +0.01 (+0.02%)
As of 05/28/2025 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TC Energy Corporation operates as an energy infrastructure company in North America. It operates through five segments: Canadian Natural Gas Pipelines; U.S. Natural Gas Pipelines; Mexico Natural Gas Pipelines; Liquids Pipelines; and Power and Energy Solutions. The company builds and operates a network of 93,600 kilometers of natural gas pipelines, which transports natural gas from supply basins to local distribution companies, power generation plants, industrial facilities, interconnecting pipelines, LNG export terminals, and other businesses. It also has regulated natural gas storage facilities with a total working gas capacity of 532 billion cubic feet. In addition, it has approximately 4,900 kilometers of liquids pipeline system that connects Alberta crude oil pipeline to refining markets in Illinois, Oklahoma, Texas, and the United States Gulf Coast. Further, the company owns or has interests in power generation facilities with approximately 4,600 megawatts; and owns and operates approximately 118 billion cubic feet of non-regulated natural gas storage facilities in in Alberta, Ontario, Québec, and New Brunswick. The company was formerly known as TransCanada Corporation and changed its name to TC Energy Corporation in May 2019. TC Energy Corporation was founded in 1951 and is headquartered in Calgary, Canada.